This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Prevention of Post-partum Haemorrhage (TRACOR)

This study has been completed.
Sponsor:
Collaborator:
Institut National de la Santé Et de la Recherche Médicale, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01044082
First received: January 6, 2010
Last updated: July 25, 2012
Last verified: March 2012
  Purpose

The primary purpose of the trial is to evaluate whether the management of placental delivery with controlled cord traction (CCT) reduces the incidence of postpartum haemorrhage, compared with management waiting for clinical signs of spontaneous placental separation, in women with vaginal delivery receiving prophylactic oxytocin for the management of the third stage of labour.

The hypothesis is that CCT, by reducing the length of the third stage of labour, facilitates early postpartum uterine contraction and local haemostasis and decreases post partum blood loss.


Condition Intervention
Postpartum Haemorrhage Immediate Postpartum Hemorrhage Procedure: controlled cord traction Procedure: Clinical signs of placental separation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Impact of Controlled Cord Traction During the Third Stage of Labour on the Incidence of Post Partum Haemorrhage

Resource links provided by NLM:


Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • Incidence of postpartum haemorrhage, defined as a measured postpartum blood loss greater than 500 mL [ Time Frame: immediately to two hours after delivery ]

Secondary Outcome Measures:
  • Severe postpartum haemorrhage, defined as a measured postpartum blood loss greater than 1000mL [ Time Frame: immediately to two hours after delivery ]
  • Measured postpartum blood loss at 30 minutes after delivery [ Time Frame: at 30 minutes after delivery ]
  • Total measured postpartum blood loss [ Time Frame: Time after delivery ]
  • Curative postpartum uterotonic treatment [ Time Frame: Time after delivery ]
  • Postpartum transfusion [ Time Frame: Time after delivery ]
  • Postpartum embolization or surgery for haemorrhage [ Time Frame: Time after delivery ]
  • Peripartum haemoglobin delta [ Time Frame: Time after delivery ]
  • Peripartum haematocrit delta [ Time Frame: Time after delivery ]
  • Duration of third stage of labour [ Time Frame: time before delivery ]
  • Deliveries with manual removal of placenta [ Time Frame: 30 minutes ]
  • Potential adverse events: uterine inversion, cord rupture, pain during third stage of labour [ Time Frame: Time after delivery ]
  • Woman's satisfaction [ Time Frame: two days after delivery ]

Enrollment: 4382
Study Start Date: January 2010
Study Completion Date: March 2012
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: controlled cord traction
Controlled cord traction will be applied as soon as a firm uterine contraction is obtained, and until placental delivery occurs.
Procedure: controlled cord traction
In the intervention group, controlled cord traction will be applied as soon as a firm uterine contraction is obtained, and until placental delivery occurs
Active Comparator: clinical signs of placental separation
Clinical signs of placental separation will be awaited for, and then placental expulsion may be helped through maternal pushing and/or hypogastric pressure
Procedure: Clinical signs of placental separation
Clinical signs of placental separation will be awaited for, and then placental expulsion may be helped through maternal pushing and/or hypogastric pressure

Detailed Description:

In this randomized controlled trial, conducted in 6 maternity units, information will be provided to eligible women during a prenatal visit in late pregnancy. Once in labour ward, during labour and before delivery, and if eligible and willing to participate, the woman will be randomly allocated to the intervention or reference group.

In all women, immediately after the birth of the baby, 5 IU prophylactic oxytocin will be intravenously administered, the umbilical cord will be early clamped and cut, and a collector bag placed under the woman's buttocks.

In the intervention group, controlled cord traction will be applied as soon as a firm uterine contraction is obtained, and until placental delivery occurs.

In the reference group, clinical signs of placental separation will be awaited for, and then placental expulsion may be helped through maternal pushing and/or hypogastric pressure.

All other aspects of the management of the third stage will be standardized and common to all women.

On day 2 postpartum, a venous blood sample will be collected to measure plasma haemoglobin and haematocrit. On the same day, a questionnaire will be filled in by the woman to assess her satisfaction.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria :

  • Age ≥ 18
  • Expected vaginal delivery
  • Gestational age ≥ 35 weeks
  • Singleton pregnancy

Exclusion criteria :

  • Age <18
  • Planned caesarean delivery
  • Severe hemorrhagic disease
  • Multiple Pregnancy
  • Placenta praevia
  • Intra uterine fetal death
  • No health insurance coverage
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01044082

Locations
France
Maternité de Port-Royal
Paris, France, 75014
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France
Investigators
Principal Investigator: Catherine Deneux, MD, PhD Assistance Publique - Hôpitaux de Paris
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT01044082     History of Changes
Other Study ID Numbers: P081206
AOM09161 ( Other Grant/Funding Number: AOM09161 )
Study First Received: January 6, 2010
Last Updated: July 25, 2012

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Postpartum haemorrhage
Third stage of labour
Controlled cord traction
Randomized controlled trial
Prevention

Additional relevant MeSH terms:
Hemorrhage
Postpartum Hemorrhage
Pathologic Processes
Obstetric Labor Complications
Pregnancy Complications
Puerperal Disorders
Uterine Hemorrhage

ClinicalTrials.gov processed this record on June 23, 2017